Terms: = Ovarian cancer AND NONO, Q15233, 4841, ENSG00000147140, NRB54, P54NRB, NMT55, P54
7 results:
1. A Multi-Faceted Analysis Showing
Balcerak A; Szafron LA; Rubel T; Swiderska B; Bonna AM; Konarzewska M; Sołtyszewski I; Kupryjanczyk J; Szafron LM
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673965
[No Abstract] [Full Text] [Related]
2. Splicing factor proline- and glutamine-rich (SFPQ) protein regulates platinum response in ovarian cancer-modulating SRSF2 activity.
Pellarin I; Dall'Acqua A; Gambelli A; Pellizzari I; D'Andrea S; Sonego M; Lorenzon I; Schiappacassi M; Belletti B; Baldassarre G
Oncogene; 2020 May; 39(22):4390-4403. PubMed ID: 32332923
[TBL] [Abstract] [Full Text] [Related]
3. Early ovariectomy reveals the germline encoding of natural anti-A- and Tn-cross-reactive immunoglobulin M (IgM) arising from developmental O-GalNAc glycosylations. (Germline-encoded natural anti-A/Tn cross-reactive IgM).
Arend P
Cancer Med; 2017 Jul; 6(7):1601-1613. PubMed ID: 28580709
[TBL] [Abstract] [Full Text] [Related]
4. ABO blood groups and risk of cancer: a systematic review and meta-analysis.
Zhang BL; He N; Huang YB; Song FJ; Chen KX
Asian Pac J Cancer Prev; 2014; 15(11):4643-50. PubMed ID: 24969898
[TBL] [Abstract] [Full Text] [Related]
5. ABO and Rh blood groups in relation to ovarian, endometrial and cervical cancer risk among the population of South-East Siberia.
Yuzhalin AE; Kutikhin AG
Asian Pac J Cancer Prev; 2012; 13(10):5091-6. PubMed ID: 23244116
[TBL] [Abstract] [Full Text] [Related]
6. Anticancer activity of tetracationic arene ruthenium metalla-cycles.
Barry NP; Edafe F; Therrien B
Dalton Trans; 2011 Jul; 40(27):7172-80. PubMed ID: 21660364
[TBL] [Abstract] [Full Text] [Related]
7. Target specificity of 188Re-labeled B27.1 monoclonal antibodies to ovarian cancer cells in vivo.
Palakurthi S; Wilson J; McQuarrie SA; Suresh MR; Mercer JR; Miller GG
In Vivo; 2008; 22(3):321-6. PubMed ID: 18610743
[TBL] [Abstract] [Full Text] [Related]
